Lewes, DE -- (SBWIRE) -- 09/05/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Advanced Cell Technology, Inc.(OTCBB:ACTC), LIMITLESS VENTURE(OTCMKTS:LVGI), Tribune Company(OTCMKTS:TRBAA), NanoViricides Inc(OTCBB:NNVC).
Advanced Cell Technology, Inc.(OTCBB:ACTC) ended higher +2.00% and complete the day at $0.06123. The total number of shares changed hands during the day was 7.73million. After opening at $0.06, the stock hit as high as $0.06. However, it traded between $0.05 and $0.10 over the last twelve months.
Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
For How Long ACTC will Fight for Profitability? Read This Trend Analysis report
LIMITLESS VENTURE(OTCMKTS:LVGI) closed yesterday at $0.0362, a -17.13% decrease. Around 3.81 million shares were traded, beating an-average trading volume of 163,546 shares. The company is now valued at around $ 6,300.
Limitless Venture Group Inc., together with its subsidiaries, engages in the production, distribution and marketing of wellness, anti-aging, and hormone replacement therapy products for males and females in the OTC nutraceutical sector. The company offers LIMITLESS BODY line of body care products, including Body Fresh, a body wash; Muscle Butter, a body soothing massage butter; Body Sugar
Has LVGI Found The Bottom And Ready To Gain Momentum? Find Out Here
Tribune Company(OTCMKTS:TRBAA) moved +0.74 percent higher at $60.44 and traded between $59.95 and $60.75 after opening the day at $60.00. Its performance over the last five days remained 0.07%, which stands at -5.56% for a month. Going back further than one month, 1-year performance after recent close was 6.6%.
Tribune Company, through its subsidiaries, operates as a media and entertainment company primarily in the United States. The company engages in newspaper publishing, and television and radio broadcasting
For How Long TRBAA Gloss will Attract Investors? Find out via this report
NanoViricides Inc(OTCBB:NNVC) shares rose, gaining +2.40 percent to close at $1.28. The stock is up around 175.27% this year and 96.92% for the last 12 months. Around 329,400 shares changed hands yesterday, higher from an-average trading volume of 315,344 shares.
NanoViricides, Inc., a nano-biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of viral infections. The company has two anti-influenza drug candidates at advanced pre-clinical stage which include two FluCide drugs comprising an orally bioactive nanomedicine for out-patients and an active injectable form for the treatment of hospitalized patients and serious patients in a physician office; HIVCide
Why Should Investors Buy NNVC After The Recent Gain? Just Go Here and Find Out
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/